Extra Pulmonary Sarcoidosis clinical trials

Explore recruiting extra pulmonary sarcoidosis clinical trials.

Recruiting extra pulmonary sarcoidosis studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Extra Pulmonary Sarcoidosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

HydroxyChloroquine as steroid-sparing Agent in Extra-pulmonary SARcoidosis. A multicenter, prospective, placebo-controlled, randomized trial. CAESAR

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Extra Pulmonary Sarcoidosis trials by city

Extra Pulmonary Sarcoidosis in Toronto Extra Pulmonary Sarcoidosis in Vancouver Extra Pulmonary Sarcoidosis in Montreal Extra Pulmonary Sarcoidosis in Calgary Extra Pulmonary Sarcoidosis in Edmonton Extra Pulmonary Sarcoidosis in Ottawa Extra Pulmonary Sarcoidosis in Winnipeg Extra Pulmonary Sarcoidosis in Quebec City Extra Pulmonary Sarcoidosis in Hamilton Extra Pulmonary Sarcoidosis in Kitchener Extra Pulmonary Sarcoidosis in London Extra Pulmonary Sarcoidosis in Halifax Extra Pulmonary Sarcoidosis in New York Extra Pulmonary Sarcoidosis in Los Angeles Extra Pulmonary Sarcoidosis in Chicago Extra Pulmonary Sarcoidosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease